Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure

被引:0
作者
Shengen Liao
Xinyi Lu
Iokfai Cheang
Xu Zhu
Ting Yin
Wenming Yao
Haifeng Zhang
Xinli Li
机构
[1] Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital,Department of Cardiology
来源
BMC Cardiovascular Disorders | / 21卷
关键词
Model for end-stage liver disease; Mortality; Albumin; Acute heart failure;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 129 条
[1]  
Benjamin EJ(2017)Heart disease and stroke statistics-2017 update: a report from the American Heart Association Circulation 135 e146-e603
[2]  
Blaha MJ(2009)Hospitalizations after heart failure diagnosis a community perspective J Am Coll Cardiol 54 1695-1702
[3]  
Chiuve SE(2016)Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure Eur J Heart Fail 18 1518-1521
[4]  
Cushman M(2015)Prediction of mortality using quantification of renal function in acute heart failure Int J Cardiol 201 650-657
[5]  
Das SR(2008)Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure Circ J 72 364-369
[6]  
Deo R(2013)Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction J Am Coll Cardiol 61 2253-2261
[7]  
Dunlay SM(2019)Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial ESC Heart Fail 6 1188-1198
[8]  
Redfield MM(2017)Tang WHW Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF) Am J Cardiol 119 2003-2009
[9]  
Weston SA(2016)2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 37 2129-2200
[10]  
Therneau TM(2001)A model to predict survival in patients with end-stage liver disease Hepatology 33 464-470